Assignee
ASAHI KASEI PHARMA CORP
JP·61 granted patents·33 pending applications·315 citations·filing 1997–2025
Top patents by PatentIndex Score
94 records- 0188US7618984B2Sulfonamide compoundASAHI KASEI PHARMA CORP·Filed 2006·Granted Nov 17, 2009·20 cites·13 claims
- 0288US7511069B2Indazole compounds as β3 andrenoceptor agonistASAHI KASEI PHARMA CORP·Filed 2007·Granted Mar 31, 2009·10 cites·8 claims
- 0386US7531533B26-Membered heterocyclic compound and use thereofASAHI KASEI PHARMA CORP·Filed 2006·Granted May 12, 2009·12 cites·5 claims
- 0485US7250269B2Composition for assaying glycoproteinASAHI KASEI PHARMA CORP·Filed 2002·Granted Jul 31, 2007·20 cites·20 claims
- 0583US7803792B2Quaternary ammonium compoundsASAHI KASEI PHARMA CORP·Filed 2007·Granted Sep 28, 2010·6 cites·14 claims
- 0682US7964613B2Sulfonamide compoundASAHI KASEI PHARMA CORP·Filed 2008·Granted Jun 21, 2011·16 cites·35 claims
- 0781US7994202B2Bicyclic nitrogen-containing heterocyclic compoundsASAHI KASEI PHARMA CORP·Filed 2009·Granted Aug 9, 2011·14 cites·21 claims
- 0881US7598284B2Indazole compounds as B3 adrenoceptor agonistASAHI KASEI PHARMA CORP·Filed 2007·Granted Oct 6, 2009·4 cites·11 claims
- 0981US7271190B2Indazole compounds as β3 adrenoceptor agonistASAHI KASEI PHARMA CORP·Filed 2002·Granted Sep 18, 2007·11 cites·10 claims
- 1080US10988468B2Nitrogen-containing 6-membered cyclic compoundASAHI KASEI PHARMA CORP·Filed 2018·Granted Apr 27, 2021·2 cites·10 claims
- 1180US7883862B2Diglyceride solutions for lipase activity determinationASAHI KASEI PHARMA CORP·Filed 2005·Granted Feb 8, 2011·1 cites·21 claims
- 1279US7879567B2Method for stabilizing coenzyme and composition thereforASAHI KASEI PHARMA CORP·Filed 2005·Granted Feb 1, 2011·2 cites·13 claims
- 1379US7125567B2Process for producing an oral sustained-release preparation of fasudil hydrochlorideASAHI KASEI PHARMA CORP·Filed 2003·Granted Oct 24, 2006·18 cites·16 claims
- 1479US6861444B2Bicyclic compoundsASAHI KASEI PHARMA CORP·Filed 2001·Granted Mar 1, 2005·15 cites·12 claims
- 1578US9034823B2Medicament for therapeutic treatment and/or improvement of sepsisASAHI KASEI PHARMA CORP·Filed 2014·Granted May 19, 2015·3 cites·16 claims
- 1678US7893050B2Fasudil in combination therapies for the treatment of pulmonary arterial hypertensionASAHI KASEI PHARMA CORP·Filed 2006·Granted Feb 22, 2011·7 cites·8 claims
- 1778US7312208B2Quaternary ammonium compoundsASAHI KASEI PHARMA CORP·Filed 2003·Granted Dec 25, 2007·13 cites·22 claims
- 1877US6867320B2Substituted phenylalkanoic acid derivatives and use thereofASAHI KASEI PHARMA CORP·Filed 2003·Granted Mar 15, 2005·9 cites·28 claims
- 1976US10900063B2Measurement of Lp-PLA2 activityASAHI KASEI PHARMA CORP·Filed 2017·Granted Jan 26, 2021·3 cites·13 claims
- 2076US7470807B2Substituted arylalkanoic acid derivatives and use thereofASAHI KASEI PHARMA CORP·Filed 2004·Granted Dec 30, 2008·8 cites·36 claims
- 2175US7973030B2Benzothiazepine and benzothiepine compoundsASAHI KASEI PHARMA CORP·Filed 2005·Granted Jul 5, 2011·6 cites·28 claims
- 2273US10472665B2Measuring method and composition using kinaseASAHI KASEI PHARMA CORP·Filed 2015·Granted Nov 12, 2019·1 cites·36 claims
- 2373US7452687B2Method of detecting mild impaired glucose tolerance or insulin secretory defectASAHI KASEI PHARMA CORP·Filed 2003·Granted Nov 18, 2008·4 cites·12 claims
- 2473US7094789B25-substituted isoquinoline derivativesASAHI KASEI PHARMA CORP·Filed 2003·Granted Aug 22, 2006·7 cites·50 claims
- 2572US7015345B2Propionic acid derivativesASAHI KASEI PHARMA CORP·Filed 2003·Granted Mar 21, 2006·8 cites·25 claims
- 2671US7588910B2Hemoglobin A1c determination method, enzyme to be used therefor, and production method thereofASAHI KASEI PHARMA CORP·Filed 2004·Granted Sep 15, 2009·11 cites·3 claims
- 2771US6797169B1Filter membranes for physiologically active substancesASAHI KASEI PHARMA CORP·Filed 2000·Granted Sep 28, 2004·21 cites·7 claims
- 2870US7718797B2Fasudil-containing preparation and method of improving stability thereofASAHI KASEI PHARMA CORP·Filed 2005·Granted May 18, 2010·5 cites·17 claims
- 2969US7227007B2NF-κB activating geneASAHI KASEI PHARMA CORP·Filed 2003·Granted Jun 5, 2007·11 cites·11 claims
- 3068US7160894B2Tricyclic compoundASAHI KASEI PHARMA CORP·Filed 2004·Granted Jan 9, 2007·5 cites·16 claims
- 3168US7049445B2Bicyclic compoundsASAHI KASEI PHARMA CORP·Filed 2004·Granted May 23, 2006·4 cites·3 claims
- 3268US2025222203A1Automatic injection deviceASAHI KASEI PHARMA CORP·Filed 2025·Application pending·0 cites
- 3365US11959116B2Method for producing nicotinamide mononucleotideASAHI KASEI PHARMA CORP·Filed 2022·Granted Apr 16, 2024·0 cites·11 claims
- 3465US10975411B2Method and reagent for measuring mevalonic acid, 3-hydroxymethylglutaryl coenzyme A, and coenzyme AASAHI KASEI PHARMA CORP·Filed 2016·Granted Apr 13, 2021·0 cites·4 claims
- 3563US7754752B2Crystals of substituted phenylalkanoic acid and method of producing the sameASAHI KASEI PHARMA CORP·Filed 2009·Granted Jul 13, 2010·0 cites·9 claims
- 3662US7582658B2Bicyclic compoundASAHI KASEI PHARMA CORP·Filed 2004·Granted Sep 1, 2009·3 cites·18 claims
- 3762US6699508B1Sustained release oral preparations of fasudil hydrochlorideASAHI KASEI PHARMA CORP·Filed 1999·Granted Mar 2, 2004·20 cites·11 claims
- 3862US2009062530A1Substituted arylalkanoic acid derivatives and use thereofASAHI KASEI PHARMA CORP·Filed 2008·Application pending·0 cites
- 3962US2009042279A1Method of detecting mild impaired glucose tolerance or insulin secretory defectASAHI KASEI PHARMA CORP·Filed 2008·Application pending·0 cites
- 4061US7960392B2Nitrogen-containing heterocyclic compoundsASAHI KASEI PHARMA CORP·Filed 2009·Granted Jun 14, 2011·1 cites·26 claims
- 4161US2010048893A1Substituted arylalkanoic acid derivatives and use thereofASAHI KASEI PHARMA CORP·Filed 2008·Application pending·0 cites
- 4260US2022265930A1Automatic injection deviceASAHI KASEI PHARMA CORP·Filed 2020·Application pending·0 cites
- 4360US2021205418A1Teriparatide-containing liquid pharmaceutical composition having excellent stabilityASAHI KASEI PHARMA CORP·Filed 2021·Application pending·0 cites
- 4459US7943337B2Method for screening a proteaseASAHI KASEI PHARMA CORP·Filed 2009·Granted May 17, 2011·0 cites·6 claims
- 4559US2020289621A1Teriparatide-containing liquid pharmaceutical composition having excellent stabilityASAHI KASEI PHARMA CORP·Filed 2018·Application pending·0 cites
- 4658US11667630B2Nitrogen-containing 6-membered cyclic compoundASAHI KASEI PHARMA CORP·Filed 2021·Granted Jun 6, 2023·0 cites·19 claims
- 4758US11541104B2Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a weekASAHI KASEI PHARMA CORP·Filed 2021·Granted Jan 3, 2023·0 cites·2 claims
- 4858US9592275B2Medicament for therapeutic treatment and/or improvement of sepsisASAHI KASEI PHARMA CORP·Filed 2012·Granted Mar 14, 2017·0 cites·1 claims
- 4958US9555080B2Medicament for therapeutic treatment and/or improvement of sepsisASAHI KASEI PHARMA CORP·Filed 2016·Granted Jan 31, 2017·0 cites·26 claims
- 5058US7560478B2Crystal forms of substituted phenylalkanoic acids and process for producing the sameASAHI KASEI PHARMA CORP·Filed 2007·Granted Jul 14, 2009·0 cites·10 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ASAHI KASEI PHARMA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →